Integrative single cell analysis provides a unique set of challenges. With single cell already playing an important role for drug discovery, join us as we discuss the lessons learned from global pharma companies as we implement, refine protocols and apply the technology across the R&D pipeline.

Join us for three insightful presentations:

“Pooled CRISPR screening with single cell RNA seq read-out in cancer cells” – Antoine De Weck, Team Lead, Oncology Data Science, Novartis

“Network Analysis and Human Single Cell Brain Transcriptomics Reveal Novel Aspects of Alpha-Synuclein (SNCA) Biology”– Dinesh Kumar, Principal Scientist, Sanofi

"Leveraging single-cell analysis to unravel treatment resistance mechanisms and monitor minimal residual disease" - Kelly Kaihara, Ph.D., Applications Manager, MissionBio